Amdocs Valuation
| DOX Stock | USD 84.89 0.21 0.25% |
At this time, the firm appears to be undervalued. Amdocs shows a prevailing Real Value of $94.1 per share. The current price of the firm is $84.89. Our model approximates the value of Amdocs from analyzing the firm fundamentals such as profit margin of 0.1 %, and Return On Equity of 0.14 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Amdocs' valuation include:
Price Book 2.7636 | Enterprise Value | Enterprise Value Ebitda 12.0007 | Price Sales 1.9135 | Forward PE 12.1803 |
Undervalued
Today
Please note that Amdocs' price fluctuation is very steady at this time. Calculation of the real value of Amdocs is based on 3 months time horizon. Increasing Amdocs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Amdocs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Amdocs Stock. However, Amdocs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 84.89 | Real 94.1 | Target 102.12 | Hype 84.86 |
The intrinsic value of Amdocs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Amdocs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Amdocs helps investors to forecast how Amdocs stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Amdocs more accurately as focusing exclusively on Amdocs' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Amdocs' intrinsic value based on its ongoing forecasts of Amdocs' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Amdocs' closest peers.
Amdocs Cash |
|
Amdocs Valuation Trend
Analysing the historical paterns of Amdocs' enterprise value and its market capitalization is a good way to estimate and gauge the value of Amdocs over time and is usually enough for investors to make rational market timing decisions.
Amdocs Total Value Analysis
Amdocs is currently estimated to have company total value of 9.83 B with market capitalization of 9.58 B, debt of 789.74 M, and cash on hands of 817.98 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Amdocs fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.83 B | 9.58 B | 789.74 M | 817.98 M |
Amdocs Investor Information
About 100.0% of the company shares are held by institutions such as insurance companies. The book value of Amdocs was currently reported as 30.39. The company has Price/Earnings To Growth (PEG) ratio of 1.11. Amdocs last dividend was issued on the 31st of December 2024. The entity had 1:4 split on the December 1, 2003. Based on the key indicators related to Amdocs' liquidity, profitability, solvency, and operating efficiency, Amdocs is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.15 | 0.14 |
|
| |||||
| Total Cash From Operating Activities | 569.3 M | 833.1 M |
|
| |||||
| Operating Income | 414.1 M | 722.9 M |
|
|
Amdocs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Amdocs has an asset utilization ratio of 78.37 percent. This suggests that the Company is making $0.78 for each dollar of assets. An increasing asset utilization means that Amdocs is more efficient with each dollar of assets it utilizes for everyday operations.Amdocs Ownership Allocation
Amdocs holds a total of 112.82 Million outstanding shares. The majority of Amdocs outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Amdocs to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Amdocs. Please pay attention to any change in the institutional holdings of Amdocs as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Amdocs Profitability Analysis
The company reported the last year's revenue of 5 B. Total Income to common stockholders was 496.32 M with profit before taxes, overhead, and interest of 1.75 B.Amdocs Past Distributions to stockholders
About Amdocs Valuation
Our relative valuation model uses a comparative analysis of Amdocs. We calculate exposure to Amdocs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Amdocs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 B | 1.1 B | |
| Pretax Profit Margin | 0.12 | 0.11 | |
| Operating Profit Margin | 0.14 | 0.15 | |
| Net Profit Margin | 0.09 | 0.08 | |
| Gross Profit Margin | 0.40 | 0.41 |
A single share of Amdocs represents a small ownership stake in the entity. As a stockholder of Amdocs, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Amdocs Dividends Analysis For Valuation
At this time, Amdocs' Dividend Yield is fairly stable compared to the past year. Dividend Paid And Capex Coverage Ratio is likely to rise to 4.04 in 2025, whereas Dividends Paid is likely to drop slightly above 174.8 M in 2025. . Retained Earnings is likely to rise to about 8.2 B in 2025, whereas Earnings Yield is likely to drop 0.04 in 2025.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 243.8 M | 174.8 M | |
| Dividend Yield | 0.02 | 0.04 | |
| Dividend Payout Ratio | 0.49 | 0.47 | |
| Dividend Paid And Capex Coverage Ratio | 2.62 | 4.04 |
There are various types of dividends Amdocs can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Amdocs shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Amdocs directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Amdocs pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Amdocs by the value of the dividends paid out.
Amdocs Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 115.5 M | |
| Quarterly Earnings Growth Y O Y | -0.114 | |
| Forward Price Earnings | 12.1803 |
Amdocs Current Valuation Indicators
Valuation refers to the process of determining the present value of Amdocs and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Amdocs we look at many different elements of the entity such as Amdocs's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Amdocs, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Amdocs' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Amdocs' worth.Additional Tools for Amdocs Stock Analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.